首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.
Authors:S J Cryz   Jr   M M Levine   G Losonsky   J B Kaper     B Althaus
Affiliation:Swiss Serum and Vaccine Institute, CH-3001 Berne.
Abstract:Adult volunteers received a booster dose (4 x 10(8) CFU) of attenuated Vibrio cholerae CVD 103-HgR oral vaccine 15 or 24 months after primary immunization. The immune response was modest, presumably due to rapid clearance of the vaccine strain by a primed immune system.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号